EGFR inhibitor – Globalstar International https://export.globalstarco.com Making Health Accessible. Thu, 05 Mar 2026 10:03:15 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://export.globalstarco.com/wp-content/uploads/2025/07/cropped-Site-Icon-32x32.png EGFR inhibitor – Globalstar International https://export.globalstarco.com 32 32 Rituximab (500 mg) https://export.globalstarco.com/product/rituximab-500-mg/ https://export.globalstarco.com/product/rituximab-500-mg/#respond Wed, 18 Feb 2026 10:55:10 +0000 https://export.globalstarco.com/product/rituximab-500-mg/ Overview: Erlotinib 150 mg Tablets contain Erlotinib (150 mg) and are prescribed as an oral targeted anticancer medicine used in the treatment of epidermal growth factor receptor (EGFR) mutation positive non-small cell lung cancer (NSCLC) and certain pancreatic cancers by inhibiting cancer cell growth signaling pathways. Key Benefits: – Targets EGFR pathways to slow tumor progression in NSCLC – Oral dosing for convenient outpatient treatment – Also used in select pancreatic cancer protocols Composition: Erlotinib (150 mg) How It Works: Erlotinib blocks the tyrosine kinase activity of the epidermal growth factor receptor (EGFR), preventing downstream signaling that drives cancer cell proliferation and survival, helping to slow tumor growth. Usage Instructions: – Take exactly as directed by your oncologist – Swallow the tablet whole with water, with or without food – Do not crush or chew the tablet Side Effects: – Rash, diarrhea, nausea – Fatigue, loss of appetite – Rare liver enzyme elevations Precautions: – Monitor liver function and skin reactions during treatment – Not recommended during pregnancy or breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/rituximab-500-mg/feed/ 0
Gefitinib (250 mg) https://export.globalstarco.com/product/gefitinib-250-mg/ https://export.globalstarco.com/product/gefitinib-250-mg/#respond Wed, 18 Feb 2026 10:55:05 +0000 https://export.globalstarco.com/product/gefitinib-250-mg/ Overview: Afzanna 30 mg Afatinib Tablets contain Afatinib (30 mg) and are prescribed as an oral targeted anticancer medicine for the treatment of EGFR-mutated non-small cell lung cancer (NSCLC) by blocking specific signaling pathways that promote cancer cell growth. Key Benefits: – Targets EGFR signaling to slow tumor progression in NSCLC – Oral dosing for outpatient convenience – Used in patients with confirmed EGFR mutations Composition: Afatinib (30 mg) How It Works: Afatinib is an irreversible tyrosine kinase inhibitor that blocks EGFR and related growth factor receptors, reducing cancer cell proliferation and tumor growth in susceptible NSCLC cases. Usage Instructions: – Take exactly as directed by your oncologist – Swallow the tablet whole with water, with or without food – Do not crush or chew the tablet Side Effects: – Diarrhea, rash, acne-like skin reactions – Nausea, vomiting, mouth sores – Fatigue, decreased appetite Precautions: – Not recommended during pregnancy or breastfeeding — discuss with healthcare provider before use – Monitor liver function tests during treatment – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/gefitinib-250-mg/feed/ 0
Tamoxifen Citrate (10 mg) https://export.globalstarco.com/product/tamoxifen-citrate-10-mg/ https://export.globalstarco.com/product/tamoxifen-citrate-10-mg/#respond Wed, 18 Feb 2026 10:55:05 +0000 https://export.globalstarco.com/product/tamoxifen-citrate-10-mg/ Overview: Geftinat 250 mg Tablets contain Gefitinib (250 mg) and are prescribed as an oral targeted anticancer medicine for the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC) by blocking cancer cell growth signals. Key Benefits: – Targets EGFR pathways to slow tumor progression in NSCLC – Oral dosing for convenient outpatient treatment – Used in patients with confirmed EGFR mutations Composition: Gefitinib (250 mg) How It Works: Gefitinib is an epidermal growth factor receptor (EGFR) inhibitor that blocks receptor signaling involved in cancer cell proliferation, helping control tumor growth in susceptible NSCLC patients. Usage Instructions: – Take exactly as directed by your oncologist – Swallow the tablet whole with water, with or without food – Do not chew or crush the tablet Side Effects: – Diarrhea, rash, acne-like skin reactions – Nausea, vomiting, fatigue – Loss of appetite, mouth sores Precautions: – Not recommended during pregnancy or breastfeeding without medical advice – Monitor liver function tests during treatment – Inform your doctor of all current medications to avoid interactions Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

]]>
https://export.globalstarco.com/product/tamoxifen-citrate-10-mg/feed/ 0